X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (27) 27
index medicus (27) 27
oncology (20) 20
female (18) 18
middle aged (16) 16
male (15) 15
adult (13) 13
aged (13) 13
cancer (12) 12
survival (12) 12
chemotherapy (10) 10
prognosis (10) 10
original (8) 8
original article (8) 8
retrospective studies (8) 8
aged, 80 and over (7) 7
immunohistochemistry (7) 7
patients (7) 7
therapy (7) 7
breast cancer (6) 6
care and treatment (6) 6
kaplan-meier estimate (6) 6
medicine & public health (6) 6
metastasis (6) 6
treatment outcome (6) 6
tumors (6) 6
의약학 (6) 6
analysis (5) 5
animals (5) 5
antineoplastic agents - therapeutic use (5) 5
breast neoplasms - drug therapy (5) 5
breast neoplasms - mortality (5) 5
breast neoplasms - pathology (5) 5
disease-free survival (5) 5
expression (5) 5
growth (5) 5
health aspects (5) 5
hematology (5) 5
medical prognosis (5) 5
multivariate analysis (5) 5
mutation (5) 5
neovascularization (5) 5
research (5) 5
risk factors (5) 5
angiogenesis (4) 4
confidence intervals (4) 4
costs and cost analysis (4) 4
endothelial progenitor cell (4) 4
gene expression (4) 4
genetics (4) 4
hospitals (4) 4
leukemia (4) 4
medicine (4) 4
medicine, general & internal (4) 4
metastases (4) 4
mice (4) 4
patient outcomes (4) 4
platinum (4) 4
proportional hazards models (4) 4
republic of korea (4) 4
research article (4) 4
transplantation (4) 4
5-fluorouracil (3) 3
abridged index medicus (3) 3
activation (3) 3
adolescent (3) 3
apoptosis (3) 3
biochemistry & molecular biology (3) 3
biotechnology & applied microbiology (3) 3
breast neoplasms - metabolism (3) 3
cancer patients (3) 3
cancer therapies (3) 3
carcinoma, non-small-cell lung - drug therapy (3) 3
case report (3) 3
cell biology (3) 3
cell movement (3) 3
diagnosis, differential (3) 3
endothelial progenitor cells (3) 3
follow-up (3) 3
follow-up studies (3) 3
gastric cancer (3) 3
growth-factor (3) 3
hematopoietic stem cell transplantation (3) 3
intercellular signaling peptides and proteins - metabolism (3) 3
internal medicine (3) 3
ischemia (3) 3
lung cancer (3) 3
medical colleges (3) 3
medical diagnosis (3) 3
medical research (3) 3
medicine and health sciences (3) 3
medicine, research & experimental (3) 3
multidisciplinary sciences (3) 3
neoplasm metastasis (3) 3
proteins (3) 3
repair (3) 3
science (3) 3
stomach cancer (3) 3
studies (3) 3
surgery (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 4_suppl, pp. 66 - 66
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. 4079 - 4079
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1902 - 1902
Abstract Background Patients with chronic myeloid leukemia (CML) encounter lifelong treatment. Incidence and severity of adverse events (AEs) of tyrosine... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 5981 - 5981
Abstract Introduction Although most of the studies about health related quality of life (HRQoL) focuses on acute leukemia survivors, few studies compared the... 
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 03/2018, Volume 45, Issue 3, pp. 328 - 339
PurposeTo explore whether integrated 18F-FDG PET/MRI can be used to predict pathological response to neoadjuvant chemotherapy (NAC) in patients with breast... 
Neoadjuvant chemotherapy | Breast cancer | PET/MRI | PET | Response prediction | Edema | Positron emission | Acetylcysteine | Parameter sensitivity | Patients | Sensitivity | Chemotherapy | Magnetic resonance imaging | Biopsy | Surgery | Predictions | Tomography | Glycolysis | Breast | Positron emission tomography | Cancer | Tumors
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 2318 - 2318
Journal Article
by Kim, JW and Lee, KH and Suh, KJ and Nam, AR and Bang, JH and Bang, YJ and Oh, DY
BRITISH JOURNAL OF CANCER, ISSN 0007-0920, 08/2019, Volume 121, Issue 4, pp. 332 - 339
BACKGROUND: A phase Ib study of binimetinib and capecitabine for gemcitabine-pretreated biliary tract cancer (BTC) patients was conducted. METHODS: Binimetinib... 
SURVIVAL | CHOLANGIOCARCINOMA | 5-FLUOROURACIL | CELLS | ONCOLOGY | GROWTH | KINASE | INHIBITOR | INTERLEUKIN-6 | MEK162 | GEMCITABINE | Biliary tract | Gemcitabine | Toxicity | Extracellular signal-regulated kinase | Antitumor activity | Raf protein | Mutation | Disease control | Survival | Cancer | Anticancer properties | Tumors
Journal Article
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 3/2018, Volume 67, Issue 3, pp. 459 - 470
We investigated inflammatory markers such as the neutrophil-to-lymphocyte ratio (NLR) that may predict the response to anti-PD-1 (programmed cell death protein... 
Prognostic value | Immunology | Prognosis | Medicine & Public Health | Neutrophil-to-lymphocyte ratio | Anti-PD-1 antibody | Immunotherapy | Oncology | Cancer Research | SURVIVAL | MANAGEMENT | IMMUNOLOGY | CHEMOTHERAPY | METASTATIC MELANOMA | PREDICTS PROGNOSIS | ONCOLOGY | PRETREATMENT NEUTROPHIL | EXPERIENCE | NIVOLUMAB | EXPRESSION | IPILIMUMAB | Lung Neoplasms - drug therapy | Adenocarcinoma - pathology | Follow-Up Studies | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Lung Neoplasms - metabolism | Middle Aged | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Adenocarcinoma - metabolism | Aged, 80 and over | Adult | Female | Retrospective Studies | Neutrophils - pathology | Carcinoma, Non-Small-Cell Lung - pathology | Carcinoma, Non-Small-Cell Lung - metabolism | Survival Rate | Adenocarcinoma - drug therapy | Lymphocytes - pathology | Carcinoma, Squamous Cell - drug therapy | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Viral antibodies | Complications and side effects | Liver cancer | Medical colleges | Care and treatment | Lymphocytes | Cell death | Analysis | Antibodies | Metastasis | Lung cancer, Non-small cell | Brain | PD-1 protein | Liver | Lung cancer | Neutrophils | Non-small cell lung carcinoma | Inflammation | Multivariate analysis | Survival | Patients | Metastases | Confidence intervals | Medical prognosis | Bioindicators | Movement disorders | Cancer | Apoptosis
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 2814 - 2814
Journal Article
International journal of molecular sciences, ISSN 1661-6596, 10/2018, Volume 19, Issue 10, p. 3164
Journal Article
by Lee, DW and Ryu, HS and Jin, MS and Lee, KH and Suh, KJ and Youk, J and Kim, JY and Min, A and Lee, HB and Moon, HG and Kim, TY and Han, SW and Oh, DY and Han, W and Park, IA and Noh, DY and Im, SA
BRITISH JOURNAL OF CANCER, ISSN 0007-0920, 07/2019, Volume 121, Issue 3, pp. 230 - 236
BACKGROUND: Immune cells in the tumour microenvironment play an essential role in tumorigenesis. This study aimed to evaluate the immunoregulatory protein... 
TUMOR-INFILTRATING LYMPHOCYTES | TARGET | PEMBROLIZUMAB | THERAPY | ONCOLOGY | IMMUNOTHERAPY | PROGNOSIS | MARKER | B7-H3 LIGAND EXPRESSION | CELL | CHEMOTHERAPY | Risk groups | PD-1 protein | Immunoregulation | Markers | Breast cancer | Multivariate analysis | Risk analysis | ErbB-2 protein | B7 antigen | Proteins | Ox40L protein | Tumor necrosis factor | Lymphocytes | PD-L1 protein | Breast | Protein expression | Tumorigenesis | Tumors | Immune system
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 4_suppl, pp. 843 - 843
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2018, Volume 13, Issue 10, p. e0205853
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2018, Volume 13, Issue 6, p. e0198544
Journal Article
International Journal of Hematology, ISSN 0925-5710, 8/2017, Volume 106, Issue 2, pp. 229 - 239
We analyzed adverse events (AEs) in 201 chronic phase CML patients treated with nilotinib (n = 120) or dasatinib (n = 81) as first- or second-line therapy. The... 
Nilotinib | Dasatinib | Discontinuation | Medicine & Public Health | Hematology | Toxicity | Pleural effusion | Oncology | CHRONIC MYELOGENOUS LEUKEMIA | MANAGEMENT | PULMONARY ARTERIAL-HYPERTENSION | VALIDATION | FOLLOW-UP | FAILURE | IMATINIB-RESISTANT | INTOLERANT | HEMATOLOGY | KINASE INHIBITOR TREATMENT | Pleural Effusion - chemically induced | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Pleural Effusion - epidemiology | Male | Survival Rate | Clinical Trials as Topic | Protein Kinase Inhibitors - adverse effects | Vascular Diseases - epidemiology | Vascular Diseases - chemically induced | Young Adult | Antineoplastic Agents - adverse effects | Deprescriptions | Adolescent | Pyrimidines - adverse effects | Aged, 80 and over | Adult | Female | Aged | Dasatinib - adverse effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality | Practice Guidelines as Topic | Protein-Tyrosine Kinases - antagonists & inhibitors | Hypertension | Stroke (Disease) | Antimitotic agents | Complications and side effects | Medical colleges | Clinical trials | Antineoplastic agents | Coronary heart disease | Medical research | Stroke | Interruption | Effusion | Myeloid leukemia | Pulmonary arteries | Leukemia | Medical services | Chronic myeloid leukemia | Patients | Survival | Pulmonary artery | Acute coronary syndromes | Index Medicus
Journal Article
Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. 4739 - 4739
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.